Activity of combinations of bactericidal and bacteriostatic compounds in Mycobacterium abscessus-infected mice: an overview
Treatment of Mycobacterium abscessus (MAB) infections is complicated by the lack of bactericidal antibiotics, the ability of MAB to persist in the hypoxic environment of granulomas and the intrinsic antibiotic resistance, which results in patient treatment with drug combinations for several months....
Saved in:
Main Authors: | Alessio Lanni, Elisabetta Iona, Lanfranco Fattorini, Federico Giannoni, Angelo Iacobino |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-08-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1616149/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mycobacterium abscessus Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report
by: Daisy Lu, et al.
Published: (2025-07-01) -
The Advance and Clinical Practice on Lung Disease Caused by Mycobacterium abscessus
by: Zhang L, et al.
Published: (2025-06-01) -
Evolution of Mycobacterium abscessus in the human lung: Cumulative mutations and genomic rearrangement of porin genes in patient isolates
by: Shamira J. Shallom, et al.
Published: (2023-12-01) -
Pathogen genotypes and host phenotypes of Mycobacterium abscessus pulmonary disease in Taiwan
by: Yu-Hsun Chiang, et al.
Published: (2025-10-01) -
Successful long-term management for postoperative sternal infection with multiple disseminated lymphadenitis caused by Mycobacterium abscessus
by: Takahiro Yanagihara, et al.
Published: (2023-08-01)